| | | |

Antioxidant Supplements for Mesothelioma Patients Might be Dangerous

antioxidant supplements for mesothelioma patients

Two separate lung cancer studies suggest that antioxidant supplements for mesothelioma patients may not be advisable. 

The studies appear in the most recent issue of the medical journal Cell

Both focus on the role of antioxidants in the growth and spread of lung cancer. Although mesothelioma is not the same as lung cancer, it affects the same area of the body and shares many of the same characteristics. 

The new research suggests that, instead of fighting cancer, antioxidant supplements for mesothelioma patients, might actually help it grow. 

Supplements for Cancer Patients

Antioxidant vitamins like A, C, and E are plentiful in fruits and vegetables. Many people take antioxidant supplements to make up for a poor diet. These vitamins can help protect the body from the damaging effects of “free radicals”. Free radicals are produced when the body is under stress from disease or environment. 

Cancer patients like those with pleural mesothelioma may take supplements to make up for nutrients they are not getting because they do not feel like eating. Both the cancer and the treatment can deplete the body, just when it needs to be strong. 

But the new studies suggest that higher levels of antioxidants are not a good idea for everyone. Antioxidant supplements for mesothelioma patients could do more harm than good. 

Antioxidant Supplements for Mesothelioma: What is the Connection?

Free radicals damage cells. Cancer cells produce – and get exposed to – a lot of free radicals because they are burning so much glucose. That high metabolism is what makes cancer cells show up on PET scans. 

But mesothelioma cells and other types of cancer cells can protect themselves from free radicals with antioxidants. The studies show cancer cells can either take antioxidants from the diet or they can make them. About thirty percent of lung cancer cells are capable of making their own antioxidants. 

Antioxidant supplements for mesothelioma patients may allow a protein called BACH1 to accumulate in the cancer cells. BACH1 is one of the signals that appears to tell cancer cells to spread.

“We now have important new information on lung cancer metastasis, making it possible for us to develop new treatments, such as ones based on inhibiting BACH1,” Swedish study author Martin Bergo, professor of Biosciences and Nutrition at Karolinska Institutet, said in a statement. 

In 2014, Bergo and his team suggested that Vitamin E supplements could fuel cancer growth. This new study takes the findings further to show how it might happen.

Michele Pagano, MD, is the senior author of a similar NYU School of Medicine Study. She and her team plan to study how the information could be used to help prevent lung cancer spread.

In the meantime, the safety of antioxidant supplements for mesothelioma patients and those with other types of cancer remains unclear.

Wiel, C, et al, “BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis”, June 27, 2019, Cell, https://doi.org/10.1016/j.cell.2019.06.005

Lignitto, L, et al, “Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1”, June 27, 2019, Cell, https://doi.org/10.1016/j.cell.2019.06.003

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • | | |

    Human Trials Planned for Promising New Mesothelioma Drug

    The Australian Asbestos Diseases Research Institute says it is ready to begin human trials on what its lead researcher calls the first significant advance in mesothelioma treatment in a decade. More than three years in development, TargomiRs utilizes a unique ‘minicell’ delivery system to insert a synthetic form of missing genetic material into mesothelioma cells. Like a number of other types of cancer, mesothelioma cells are missing a family of microRNAs critical to regulating the cellular life cycle. TargomiRs restores these microRNAs. In mice with human-derived mesothelioma, TargomiRs produced a “remarkable inhibition of tumour growth”, according to the Asbestos Diseases Research Institute. “The last significant development in the treatment of mesothelioma occurred ten years ago,” ADRI director Nico van Zandwijk…